SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi Consumer Healthcare India submits board meeting intimation

20 Feb 2026 Evaluate

Sanofi Consumer Healthcare India has informed that this is with reference to letter dated 17th February 2026, wherein meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 25th February 2026, to consider and approve the Audited Financial Statements for the Quarter and Financial Year ended 31st December 2025. In furtherance of the above, they informed Sanofi Consumer Healthcare India's Board of Directors may also consider the recommendation of dividend, if any, for the Financial Year ended 31st December 2025 at the aforesaid meeting to be held on Wednesday, 25th February 2026.

The above information is a part of company’s filings submitted to BSE. 

Sanofi Cons. Health Share Price

4705.50 -17.55 (-0.37%)
21-Apr-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.90
Dr. Reddys Lab 1222.90
Cipla 1231.00
Zydus Lifesciences 932.25
Lupin 2327.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×